BCDA Stock Analysis: Buy, Sell, or Hold?
BCDA - BioCardia, Inc. Common Stock
$1.23
-0.03 (-2.38%)
▼
5d:
-8.21%
30d:
+4.24%
90d:
-6.11%
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 25, 2026
Get Alerted When BCDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BCDA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BCDA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BCDA is currently trading at $1.23, which is considered oversold relative to its 30-day fair value range of $1.25 to $1.37.
Technical Outlook: Technically, BCDA is in a downtrend. The price is currently testing key support at $1.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BCDA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.50 (+1160.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BCDA is in a downtrend. The price is currently testing key support at $1.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BCDA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.50 (+1160.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.25 -
$1.37
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1160.2% below Wall St target ($15.50)
- CAUTION: 5-day price weakness (-8.2%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.25 -
$1.37
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.21
Resistance Level
$1.43
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.78
Wall Street Target
$15.50
(+1160.2%)
Revenue Growth (YoY)
-100.0%
Last updated: February 01, 2026 11:18 PM ET
Data refreshes hourly during market hours. Next update: 12:18 AM
Data refreshes hourly during market hours. Next update: 12:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCDA showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Peter Altman
BUY
48000 shares
2025-09-19
Simon H Stertzer
BUY
398400 shares
2025-09-19
Andrew Scott Blank
BUY
288000 shares
2025-09-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$514 | 62 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 60 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 61 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$217 | 53 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 55 HOLD |